Precision Flows Through
the Lipidome
40K+
Lipid Structures
8
Lipid Categories
100%
Patient-Centered
Board
Certified Standard
Lip·i·dom·ics
/ ˌlipəˈdōmiks / · noun
noun · precision scienceThe large-scale study of the complete set of lipids in a cell, tissue, or organism - their structures, functions, and interactions - and the clinical application of that knowledge to human health.
Origin
From Greek lipos (fat) + -omics (study of a complete set). The term emerged in the early 2000s, as advances in mass spectrometry made it possible to measure thousands of lipid species at once.
The Lipidomics Department at the American Board of Precision Medicine translates the science of the human lipidome into actionable clinical knowledge - equipping physicians to interpret lipid profiles, identify cardiometabolic and inflammatory risk, and personalize care at the molecular level.
From mass spectrometry-based lipid profiling and advanced lipoprotein analysis to membrane biology and inflammatory signaling, this department bridges the gap between laboratory discovery and bedside practice - training clinicians to see far beyond the standard cholesterol panel.
Grounded in rigorous board standards and driven by an interdisciplinary framework, lipidomics at ABOPM is not a niche specialty - it is a window into metabolic health and a core pillar of precision care.
40K+
Lipid Structures Cataloged
8
Lipid Categories
∞
Clinical Possibilities
Where the Lipidome Meets
Clinical Purpose
The Lipidomics Department at ABOPM exists at the intersection of metabolic science and patient care — training physicians to profile the lipidome, interpret its signals, and transform outcomes in cardiometabolic, inflammatory, and neurological health.
Advancing research in mass spectrometry-based lipid profiling, lipid mediators, and membrane composition — expanding our understanding of how lipid biology drives human disease.
Bridging the gap between laboratory lipidomics and bedside medicine — developing board-certified frameworks for advanced lipid testing, cardiometabolic risk assessment, and targeted nutritional and therapeutic intervention.
Building the next generation of lipidomics-fluent clinicians through rigorous board standards, interdisciplinary training, and collaboration across medicine, nutrition, and molecular science.
"Cholesterol is only the first chapter. The lipidome tells the whole story — and the Lipidomics Department at ABOPM trains physicians to read it, interpret it, and act on it with precision and purpose."
— American Board of Precision Medicine · Lipidomics DepartmentTranslating the Lipidome
Into Clinical Impact
Thousands of distinct lipids shape every cell membrane, signaling pathway, and energy store in the body. Learning to read the lipidome is not optional for the future of medicine — it is foundational.
Lipidomics equips clinicians to look beyond the standard cholesterol panel and into the molecular drivers of cardiometabolic disease, inflammation, and neurodegeneration — enabling earlier detection, more precise therapeutics, and care that is truly individualized at the metabolic level.
By mastering lipidomics, clinicians gain the power to:
Why Lipidomics Fluency Is Non-Negotiable
The science is here. The clinical tools are ready. The question is, are you?
Lipid-guided care looks past LDL cholesterol alone to uncover residual cardiovascular risk, target inflammation, and enable true preventive medicine.
Advanced markers like apoB and Lp(a) are moving into mainstream guidelines. Clinicians who can interpret the full lipid picture will lead; those who can't will be left behind.
Board certification in lipidomics establishes you as a recognized leader, differentiating your expertise in an era where precision medicine is the standard of care.
Lipidomics connects every specialty: cardiology, endocrinology, neurology, oncology, nutrition - giving you tools that transcend clinical silos.
Active research areas driving lipidomic medicine forward:
The lipidomic revolution is not a future event - it is happening now. High-resolution mass spectrometry, advanced lipoprotein testing, and lipid-based risk markers are actively reshaping how disease is detected, treated, and prevented at the molecular level.
The ABOPM Lipidomics Department positions clinicians at the center of this transformation - equipping them with the scientific literacy, clinical frameworks, and board-certified credentials to lead lipidomic medicine in any specialty.
Meet Our Leadership
— Director of Lipidomics —
Akash Patel, MD
Dr. Patel is a cardiology fellow at the University of Chicago, completing a dedicated lipid fellowship under Dr. Michael Davidson. His clinical focus is preventive cardiology and the management of complex and inherited lipid disorders. He earned his MD and MBA from Northwestern University.
Outside clinical practice, he previously served as Chief Business Officer at Tell Health and consults for digital health and genomics companies. As Director of Lipidomics at ABOPM, he focuses on translating lipid and lipoprotein biomarkers into evidence-based clinical decisions.
Faculty Members
Our faculty roster is growing — announcements coming soon.
Faculty position open
Faculty position open
Faculty position open
Faculty position open
Think you're the right fit for a faculty position?
Get Involved →
Shaping the Future
of Precision Medicine
As precision medicine continues to evolve, genomics will play an increasingly central role in redefining how disease is understood, predicted, and treated at the molecular level.
The Genomics Department at ABOPM remains committed to advancing this field through scientific leadership, clinical innovation, and collaborative discovery. Together with our global community of physicians and researchers, we are helping shape the future of next-generation healthcare.
Insights Shaping
Precision Medicine
Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.
From Lab Report to Treatment Plan: Interpreting Molecular Diagnostics
Explore how clinicians interpret molecular diagnostic reports and translate genomic, transcriptomic, and proteomic findings into informed, personalized treatment decisions. ...more
Precision Medicine in Action
October 08, 2026•8 min read
Biomarkers That Matter: The Molecular Signals Guiding Oncology Treatment
Discover how molecular biomarkers such as HER2, KRAS, and PD-L1 are helping guide treatment selection, clinical trials, and personalized cancer care. ...more
Precision Oncology
October 01, 2026•8 min read
Multiple Sclerosis and the Microbiome: What Emerging Research Is Teaching Us About Precision Medicine
Emerging research is uncovering connections between multiple sclerosis, the gut microbiome, genetics, and immune function. Explore what these findings could mean for the future of precision medicine. ...more
Population Precision
September 24, 2026•11 min read
Stay at the Forefront of Precision Medicine
Subscribe to receive ABOPM insights, research updates, and educational resources delivered directly to your inbox.
Advancing education, certification, and leadership to shape a genomics-driven, data-intelligent future of healthcare.
COMPANY
RESOURCES
© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.